Reliability and Validity of The Figure of 8 Walk Test With and Without Dual-Task

August 4, 2024 updated by: Emel Taşvuran Horata, Afyonkarahisar Health Sciences University

Reliability and Validity of the Figure of 8 Walk Test With and Without Dual-Task in Individuals With Stroke

For people with stroke, walking on a curved path is more difficult than walking on a straight path and can lead to falls. Most of the outcome scales assessing the gait of people with stroke involve walking in a straight line or with one turn. Assessing a person with stroke walking on a straight path may not be indicative of real-life gait-related performance. The Figure of 8 Walk Test (F8WT) includes a straight and curved gait that may represent the daily gait. To the best of our knowledge, there are no studies evaluating the reliability and validity of the dual-task F8W test in individuals with stroke. Therefore, the aim of this study was to evaluate the validity and reliability of the F8W and dual-task F8W test in individuals with stroke.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

For people with stroke, walking on a curved path is more difficult than walking on a straight path and can lead to falls. Most of the outcome scales assessing the gait of people with stroke involve walking in a straight line or with one turn. Assessing a person with stroke walking on a straight path may not be indicative of real-life gait-related performance. The Figure of 8 Walk Test (F8WT) includes a straight and curved gait that may represent the daily gait. To the best of our knowledge, there are no studies evaluating the reliability and validity of the dual-task F8W test in individuals with stroke. Therefore, the aim of this study was to evaluate the validity and reliability of the F8W and dual-task F8W test in individuals with stroke.

This prospectively designed study evaluated the demographic and clinical characteristics of the participants. The main outcome measures included the F8WT, dual-task F8WT, Standardised Mini Mental Test, The National Institutes of Health Stroke Scale, Timed-Up and Go Test, 10-metre walk test, Modified Four Square Step Test and Six-Spot Step Test.

Study Type

Observational

Enrollment (Actual)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Afyonkarahisar, Turkey, 03030
        • Afyonkarahisar Health Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The participants consisted of stroke patients aged 50 years and older who were followed up and treated by Pamukkale University Adult Neurological Rehabilitation-Outpatient Unit

Description

Inclusion Criteria:

  • 50 years of age or older,
  • Having had only one unilateral stroke at least 6 months before the study,
  • Being medically stable,
  • Being able to walk at least 10 metres with a cane or independently,
  • Getting at least 24 points from the Standardised Mini Mental Test,
  • Being able to perform the cognitive task (subtraction) given during the assessments.

Exclusion Criteria:

  • Presence of additional orthopaedic, neurological or cardiovascular diseases that may affect balance and walking,
  • Uncorrectable visual and hearing problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Stroke patients
The participants consisted of stroke patients aged 50 years and older who were followed up and treated by Pamukkale University Adult Neurological Rehabilitation - Outpatient Unit.
The test was administered two days apart to evaluate the reliability of the retest test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Figure of 8 Walk Test (F8WT)
Time Frame: The test will be administered first and third day.
The test starts from the center of two cones at a certain distance. Participants are asked to walk around the cones in 8 shapes at their normal walking speed. The test ends when the participant reaches the starting point again. The duration of the test is recorded in seconds.
The test will be administered first and third day.
Dual-task The Figure of 8 Walk Test (F8WT)
Time Frame: The test will be administered first and third day.
The test starts from the center of two cones at a certain distance. Participants were asked to walk around the cones in 8 shapes at their normal walking speed when they conducted the cognitive or motor task. The test ends when the participant reaches the starting point again. The duration of the test is recorded in seconds.
The test will be administered first and third day.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: EMEL TAŞVURAN HORATA, PhD, Afyonkarahisar Health Sciences University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 25, 2022

Primary Completion (Actual)

July 25, 2024

Study Completion (Actual)

July 25, 2024

Study Registration Dates

First Submitted

July 31, 2024

First Submitted That Met QC Criteria

August 4, 2024

First Posted (Actual)

August 6, 2024

Study Record Updates

Last Update Posted (Actual)

August 6, 2024

Last Update Submitted That Met QC Criteria

August 4, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Reliability test

Subscribe